Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

265 Views

A4. Treatment of antimicrobial resistant infections

Poster Session: Treatment of Antimicrobial Resistant Infections

(P-1519) Susceptibility of Clinical Non-Morganellaceae Enterobacterales Isolates from Bloodstream and Respiratory Tract Infections to Imipenem/Relebactam and Comparators: SMART United States 2020-2022

Friday, October 18, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Presenting Author(s)

CD

C. Andrew DeRyke, PharmD

IHMA
Schaumburg, Illinois, United States
JE

John Esterly, PhD

Merck & Co., Inc.
Rahway, New Jersey, United States
KB

Karri A. A. Bauer, PharmD

Scientific Director Medical Affairs
Merck & Co, Inc
Kenilworth, New Jersey, United States
FS

Fakhar Siddiqui, MD, MBA

Merck & Co., Inc.
Rahway, New Jersey, United States
Katherine Young, M.S. (she/her/hers)

Senior Principal Scientist
Merck
Rahway, New Jersey, United States
MM

Mary Motyl, Ph.D.

Distinguished Senior Principal Scientist
Merck
Rahway, New Jersey, United States
DS

Daniel F. Sahm, PhD

VP Global Microbiology Services & Chief Scientific Officer
IHMA
Schaumburg, Illinois, United States